2019 annual financial data

Aquestive Therapeutics 2019 Net margin

Direct answer

Net margin was -125.92%.

Operating income was -52,668,000 USD and net income was -66,246,000 USD.
Operating cash flow was -60,210,000 USD.

Get free Aquestive Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
52,609,000 USD
Operating income
-52,668,000 USD
Net income
-66,246,000 USD
Operating cash flow
-60,210,000 USD